OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 65 filers reported holding OVID THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $55,622 | -86.8% | 16,958 | -89.6% | 0.00% | – |
| Q1 2023 | $422,516 | +1785.3% | 163,766 | +1259.2% | 0.00% | – |
| Q4 2022 | $22,411 | -6.6% | 12,049 | +6.6% | 0.00% | – |
| Q2 2022 | $24,000 | -97.7% | 11,300 | -96.6% | 0.00% | – |
| Q1 2022 | $1,046,000 | -59.7% | 333,174 | -58.8% | 0.00% | – |
| Q4 2021 | $2,596,000 | +82.3% | 809,140 | +91.0% | 0.00% | – |
| Q3 2021 | $1,424,000 | +9.0% | 423,665 | +26.8% | 0.00% | – |
| Q2 2021 | $1,307,000 | -36.5% | 334,120 | -34.7% | 0.00% | – |
| Q1 2021 | $2,057,000 | +45.7% | 511,903 | -16.3% | 0.00% | – |
| Q4 2020 | $1,412,000 | +127.4% | 611,318 | +465.6% | 0.00% | – |
| Q3 2020 | $621,000 | -48.6% | 108,080 | -34.1% | 0.00% | – |
| Q2 2020 | $1,209,000 | +32.7% | 164,083 | -46.3% | 0.00% | – |
| Q1 2020 | $911,000 | +88.6% | 305,702 | +162.8% | 0.00% | – |
| Q4 2019 | $483,000 | – | 116,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
| Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
| BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
| CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
| EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
| Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
| Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
| Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
| DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |